PMDA drug package insert
クロベタゾールプロピオン酸エステル軟膏0.05%「MYK」
PMDA Prescription drug · 株式会社MAE · package insert Apr 1, 2025
Key facts
| Brand names | クロベタゾールプロピオン酸エステル軟膏0.05%「MYK」 |
|---|---|
| Nonproprietary names | クロベタゾールプロピオン酸エステル |
| Companies | 製造販売元／株式会社MAE, 販売元／日本ジェネリック株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 外用合成副腎皮質ホルモン剤 |
| Therapeutic category codes | 872646 |
| YJ codes | 2646713M1209 |
| Approval numbers | 23100AMX00056000 |
| Package insert edition | 第4版 |
| Package insert date | Apr 1, 2025 |
| PMDA document key | 730012_2646713M1209_3 |
| PMDA company code | 730012 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: